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Abstract
Background: Apis mellifera venom, which has already been recommended as an alternative anti-inflammatory
treatment, may be also considered an important source of candidate molecules for biotechnological and
biomedical uses, such as the treatment of parasitic diseases.
Methods: Africanized honeybee venom from Apis mellifera was fractionated by RP-C18-HPLC and the obtained
melittin was incubated with promastigotes and intracellular amastigotes of Leishmania (L.) infantum. Cytotoxicity to
mice peritoneal macrophages was evaluated through mitochondrial oxidative activity. The production of anti- and
pro-inflammatory cytokines, NO and H2O2 by macrophages was determined.
Results: Promastigotes and intracellular amastigotes were susceptible to melittin (IC50 28.3 μg.mL−1 and 1.4 μg.mL−1,
respectively), but also showed mammalian cell cytotoxicity with an IC50 value of 5.7 μg.mL−1. Uninfected macrophages
treated with melittin increased the production of IL-10, TNF-α, NO and H2O2. Infected melittin-treated macrophages
increased IL-12 production, but decreased the levels of IL-10, TNF-α, NO and H2O2.
Conclusions: The results showed that melittin acts in vitro against promastigotes and intracellular amastigotes of
Leishmania (L.) infantum. Furthermore, they can act indirectly on intracellular amastigotes through a macrophage
immunomodulatory effect.
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Background
In developing countries, neglected parasitic diseases
have resulted in high mortality and morbidity, especially
in tropical regions. Leishmaniasis remains an important
neglected tropical disease that affects 12 million people
in 98 countries with 20,000 to 40,000 deaths due to
visceral leishmaniasis (VL) annually [1, 2]. VL is a poten-
tially fatal disease that has emerged as an important
opportunistic condition in HIV-infected patients [3]. Its
treatment is not only challenging and long, but also
offers a limited arsenal of drugs, most of which are toxic
including antimonials, amphotericin B, pentamidine and
miltefosine [4]. The need for new treatments is crucial.
Discovering new in vitro hit compounds might be
considered relatively easier than crossing the animal-to-
human barrier, which is still a great challenge to drug
discovery programs. Bridging this gap between clinical
and basic research must be encouraged by health
professionals in order to discover effective treatments,
especially for neglected diseases [5]. The search to
develop alternative compounds, either of natural or
synthetic origin, effective for both medical therapy and
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chemoprophylaxis, should be carefully considered [6].
Likewise, Apis mellifera venom may provide an important
source of candidate molecules for application against
parasitic diseases, even though it has already been recom-
mended as an anti-inflammatory treatment [7–9].
Melittin, the major component of Apis mellifera venom,
is a cytolytic peptide that may adopt different aggregation
states and conformations depending on its concentration.
Some of its biological effects include a surfactant action
and the ability to interact and enlarge leukocytes and
mast cells by presenting detergent-like effects [10–13].
In addition to its antibacterial, antifungal, antiviral and
anti-inflammatory properties, melittin also promotes
the induction of histamine release [13]. In relation to
its antiprotozoal effect, this peptide affects the viability
and ultrastructure of trypanosomatids, including amasti-
gotes, at concentrations approximately 100 times lower
than that in mammalian cells [7]. Since Leishmania can
exhibit apoptosis induced by antimicrobial peptides,
melittin may follow the same path and then modulate cell
death [14]. Acylated synthetic cecropin A-melittin hybrid
appeared to be safe and effective for treating canine
leishmaniasis [15]. In this context, the present study aimed
to evaluate for the first time the effect of melittin as a
leishmanicidal agent against L. infantum intracellular
amastigotes. Therefore, we investigated the production of
pro- and anti-inflammatory cytokines as well as oxygen
and nitrogen metabolites in order to assess whether this
peptide would directly act on parasites, or if it would
modulate the immune response.
Methods
Venom collection
Venom from Apis mellifera Africanized honeybees
(AHBs), aged between 30 and 40 days, was extracted by
electrical stimulation, twice per week, from December
2010 to June 2011. The apiaries are located at the
Nucleus of Teaching Science and Technology in Rational
Apiculture (NECTAR) of the School of Veterinary
Medicine and Animal Husbandry, UNESP, located on the
Edgardia Experimental Farm, Botucatu, SP, Brazil, with
the following geographic coordinates: 22°49′ South
(latitude); 48°24′ West (longitude) and average altitude
of 623 m [16, 17].
Isolation and purification of melittin by high performance
reversed-phase liquid chromatography (RP-HPLC)
The isolation and purification of melittin was conducted
by RP-HPLC employing a Shimadzu 20A Proeminence
binary HPLC system and C18 column. The lyophilized
whole venom was solubilized in 0.1 % (v/v) trifluoroace-
tic acid at the concentration of 1 mg.mL−1. The samples
were centrifuged and the supernatant was separated for
chromatographic analysis. For fractioning, a two-solvent
system was utilized: (A) H2O: Trifluoroacetic acid
(TFA) (1:1000) and (B) acetonitrile (ACN):H2O:TFA
(900:100:1). The elution was performed at a constant
flow of 3.5 mL.min−1 under a linear gradient of B
(5–60 %) for 15 min and the elution was monitored at
214 nm. The peptide elution was analyzed by mass
spectrometry [16, 18].
Mass spectrometry
LC-MS analyses were performed using an electrospray-
ion trap-time of flight (ESI-IT-TOF) (Shymadzu Co.,
Japan) mass spectrometer equipped with a binary ultra-
fast liquid chromatography system (UFLC) (20A Prom-
inence, Shimadzu Co., Japan). Samples were dried,
suspended in water/formic acid (0.99/0.01, v/v) and
loaded in a C18 column (Shimadzu-pack XR-ODS,
2.2 μm; 100 × 3 mm) in a binary solvent system: (A2)
water/formic acid (FA) (999/1, v/v) and (B2) ACN/water/
FA (900/99/1, v/v/v). The column was eluted at a
constant flow rate of 0.2 mL.min−1 with a 0 to 100 %
gradient of solvent B2 for 20 min. The eluates were
monitored by a Shimadzu SPD-M20A PDA detector
before introduction into the mass spectrometer, in which
the spray voltage was kept at 4.5 kV, the capillary voltage
at 1.76 kV and the temperature at 200 °C. MS spectra
were acquired under positive mode and collected in the
80 to 2000m/z range. Instrument control, data acquisi-
tion, and data processing were performed with LabSolu-
tions (LCMSsolution 3.60.361 version, Shimadzu). Direct
mass spectrometric analyses were performed in an ESI-
IT-TOF as described above. Samples were dried and
suspended in 0.1 % FA by positive mode electrospray
ionization (ESI+). The fractions were manually injected
in a Rheodyne injector, at a flow rate 50 μL/min, in 50 %
B2. Instrument control, data acquisition, and data pro-
cessing were performed with LabSolutions (LCMSsolu-
tion 3.60.361 version, Shimadzu). Complementary mass
spectrometric analyses were performed in a Shimadzu
Axima MALDI-TOF/TOF instrument, under positive
ionization mode and employing α-cyano as matrix.
Experimental animals
Golden hamsters (Mesocricetus auratus) and BALB/c
mice were obtained from the Adolfo Lutz Institute (São
Paulo) and the Experimental Laboratory for Research on
Tropical Diseases (LEPDT), in the Department of
Tropical Diseases and Imaging Diagnosis at Botucatu
Medical School (UNESP). The animals were maintained
in sterile boxes lined with absorbent material, and
received food and water ad libitum. The golden ham-
sters were monthly infected with spleen amastigotes to
maintain the strain of Leishmania. The BALB/c mice
were utilized to obtain the peritoneal macrophages.
Animal procedures were performed in agreement with
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the Guide for the Care and Use of Laboratory Animals
from the National Academy of Sciences. This study was
approved on 07/28/2011 by the Ethics Committee on
Animal Experimentation of the Botucatu Medical
School, São Paulo State University (UNESP), Botucatu,
SP, Brazil, under protocol number CEEA 8932011.
Parasites and macrophages
Promastigotes of L. infantum (MHOM/BR/1972/LD)
were maintained in M-199 medium supplemented with
10 % fetal bovine serum (FBS) and 0.25 % hemin at 24 °
C. The amastigote forms were obtained by differential
centrifugation of the spleen from infected hamsters. The
macrophages were collected from peritoneal cavity of
BALB/c mice by washing in RPMI-1640 medium supple-
mented with 10 % fetal bovine serum and maintained at
37 °C at a tension of 5 % CO2 [19].
Determination of in vitro antileishmanial activity
To determine the 50 % inhibitory concentration (IC50)
against the promastigote forms of L. (L.) infantum, cells
were counted in a Neubauer hemocytometer and seeded at
1 × 106 cells per well in 96-well microplates. The melittin
and whole venom were dissolved in PBS and tested at
100 μg.mL−1 for melittin and 300 μg.mL−1 for whole
venom with final respective doses of 0.04 μg.mL−1
and 0.14 μg.mL−1 [19]. Miltefosine was used as a
standard drug and PBS as a negative control. The
viability was determined by the colorimetric method
of MTT [3- (4,5- dimetthythiazol-2-yl) – 2,5 diphe-
nyltetiazoliumbromide] [20].
To determine the 50 % inhibitory concentration (IC50)
against intracellular amastigotes of L. infantum, mice
peritoneal macrophages were incubated in a 1:10 ratio of
macrophages to amastigotes. Test compounds were
incubated with infected macrophages for 120 h. Subse-
quently, the cells were observed through a light micro-
scope. Miltefosine was used as the standard control
drug. Parasite burden was determined by the number of
infected macrophages out of 500 cells [21].
Cytotoxicity against peritoneal cells
Peritoneal macrophages were incubated with whole
venom and melittin, serially diluted from an initial con-
centration of 100 μg.mL−1 for melittin and of 300 μg.mL
−1 for whole venom, for 48 h at a temperature of 37 °C
in a 5 % CO2 incubator. Miltefosine was utilized as the
standard drug. The viability of cells was determined by
the MTT assay [22].
Quantification of cytokines
Macrophages were incubated with promastigote forms
of L. infantum. The infection process was similar to
that displayed by the amastigote forms. Melittin was
dissolved in PBS, being added at 0.70, 1.47 and
2.50 μg/mL. The supernatants were retrieved at 24,
48 and 72 h and maintained at −80 °C. We chose
72 h as the maximum period for evaluating levels of
cytokines since their production is reduced or even
lost in longer periods. Subsequently, the cytokines IL-
12, IL-10, TGF-β and TNF-α were measured utilizing
the Quantikine® HS kit (R&D Systems), according to
the manufacturer’s instructions [19].
Determination of nitric oxide production
The nitric oxide production (NO) was evaluated in
supernatants that had been retrieved as previously
described, by measuring nitrites (NO2
−) and nitrates
(NO3
−). Nitrite was dosed by the Griess reaction [23].
The results were read in an ELISA reader utilizing a
540 nm filter and compared with a blank solution
constituted by the Griess reaction. All measurements
were performed in triplicate. The results were expressed
in micromoles of NO/8 × 104 cells, starting from a
standard curve established in each assay, composed of
known molar concentrations of NO2
−, varying from 200
to 0.39 μM.
Determination of hydrogen peroxide production
The production of hydrogen peroxide (H2O2) was deter-
mined according to the method described by Pick and
Keisari [24] and adapted by Pick and Mizel [25]. In sum-
mary, the monolayers of macrophages were treated with
red phenol buffer solution containing 140 mM of NaCl,
10 mM of phosphate buffer, 5.5 mM of dextrose,
0.56 mM of red phenol and 0.01 mg.mL−1 of strong root
peroxidase type II (Sigma Chemical Co, USA) at pH 7.
The plates were incubated at a temperature of 37 °C, in
a 5 % CO2 incubator for 4 h, and the reaction was inter-
rupted by the addition of 0.01 mL of 1 M NaOH. The
absorbance was determined by an ELISA automatic
reader (MD 5000, Dynatech Laboratories Inc., USA),
with a 620 nm filter, using a blank solution constituted
by phenol red and 1 M NaOH. All the measurements
were performed in triplicate, and the results of H2O2
levels were expressed in nanomoles of H2O2/8 × 10
4
cells, starting from a standard curve established in each
assay, constituted from known molar concentrations of
H2O2 in phenol buffer. Under our experimental conditions,
the curve was constructed with H2O2 concentrations
of 0.5, 1.0, 2.0, 4.0 and 8 nM.
Statistical analysis
The results were expressed as standard deviation of the
mean (S.D.M.). The values obtained were submitted to
analysis of variance (ANOVA), followed by the test of
Tukey, when the number of groups was greater than
two. Non-parametric data were expressed as median and
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analyzed by the test of Mann–Whitney. The entire
analysis was performed by the software GraphPad
Prism® Version 5.01 (GraphPad Software Inc., USA).
For all the statistical tests, the significance level was
considered p < 0.05 [26].
Results
Melittin purification
Melittin was purified from Africanized honeybee (AHB)
whole venom via reversed-phase liquid chromatography,
as previously described [16–18]. Fig. 1 presents the
chromatographic profile of whole venom, identifying the
venom major peaks, namely: apamin (A), phospholipase
A2 (B) and melittin (C). Peak C was analyzed by mass
spectrometry (Fig. 1, inset) and demonstrated to contain
pure melittin.
Antileishmanial activity and macrophage cytotoxicity
Table 1 displays the viability of Leishmania promastigotes
and mammalian cytotoxicity of cells challenged with
whole venom, melittin and standard drugs. Melittin was
active against Leishmania promastigotes showing an IC50
value of 28.29 μg.mL−1 (95 % confidence interval = 23.97
to 33.39 μg.mL−1) after 48 h. The crude venom showed an
IC50 value of 87 μg.mL
−1 (95 % confidence interval = 76.91
to 99.22 μg.mL−1); miltefosine was used as the standard
drug and demonstrated an IC50 value of 6.69 μg.mL
−1
(95 % confidence interval = 6.29 to 7.11 μg.mL−1). The
statistical difference among the IC50 values of melittin,
whole venom and miltefosine was significant (p < 0.05).
Melittin also demonstrated cytotoxicity to mammalian
cells showing an IC50 value of 5.73 μg.mL
−1 (95 % confi-
dence interval = 5.08 to 6.44 μg.mL−1), while the whole
venom showed an IC50 value of 27.59 μg.mL
−1 (95 %
confidence interval = 20.63 to 36.90 μg.mL−1), differing
significantly from melittin (p < 0.05). Miltefosine was also
used as standard drug presenting an IC50 value of
49.72 μg.mL−1 (95 % confidence interval = 39.85 to
63.98 μg.mL−1) in mammalian cells.
The activity of melittin against the amastigotes was
investigated using peritoneal macrophages as host cells.
The results showed an IC50 value of 1.4 μg.mL
−1.
Although melittin was able to eliminate 100 % of intra-
cellular amastigotes at 2.5 μg.mL−1, a morphological
alteration of host cells could be observed when com-
pared to control group. However, in the concentration
of 0.7 μg.mL−1, melittin induced no toxicity to macro-
phages, but no considerable treatment could be de-
tected. Miltefosine was used as the standard drug and
showed an IC50 value of 6.87 μg.mL
−1. Considering the
selectivity index of melittin, which was determined using
the mammalian cytotoxicity by the activity against
intracellular amastigotes, we demonstrated a value of
4, confirming a higher toxic effect to Leishmania than
to mammalian cells.
Melittin effects on IL-12 and TNF-α levels
Melittin was incubated at non-toxic concentrations with
non-infected and infected macrophages while still pre-
senting an anti-amastigote effect. This concentration
was assayed for quantifying anti-inflammatory (IL-10
and TGF-β) and pro-inflammatory cytokines (IL-12 and
TNF-α). In Fig. 2, we demonstrate the effect of melittin
on IL-12 production. The IL-12 production levels by
macrophages of the control group, which was signifi-
cantly (p < 0.05) higher than the group of untreated
infected macrophages. No significant difference was
detected in IL-12 production between uninfected and
melittin-treated macrophages. But it also could be
noted that by decreasing melittin concentrations, the
IL-12 production levels dropped. Infected macro-
phages treated with melittin produced increased levels
Fig. 1 Chromatographic profile of whole venom from Africanized honeybees obtained by reversed-phase liquid chromatography indicating its
major components: (a) apamin, (b) phospholipase A2 and (c) melittin. Inset: MALDI-TOF/MS profile of melittin (peak C). The m/z value is typed
beside the peak for better visualization
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of IL-12 when compared to untreated cells. A time-
dependent production could be observed in longer
incubation periods (72 h).
The TNF-α production was also determined after
melittin treatment. Figure 3 shows that uninfected mac-
rophages, independent of melittin presence, produced
significant levels of TNF-α in a time-dependent
manner. After 72 h of incubation, uninfected cells
produced higher amounts of TNF-α (p < 0.05) when
compared to infected cells. A significant (p < 0.05)
reduction of TNF-α levels was observed when the
infected cells were treated with 2.5 μg.mL−1 of melittin.
Despite the observation of non-significant differences
(p < 0.10), infected macrophages treated with melittin at
1.47 and 0.7 μg.mL−1 demonstrated a slight increase in
TNF-α production.
Melittin effects on IL-10 and TGF-β
Elevated levels of IL-10 were produced by uninfected mac-
rophages treated with melittin, particularly at 1.47 μg.mL−1
after the 24-h incubation (p < 0.05). In Fig. 4, infected
melittin-treated macrophages demonstrated a significant
decrease of IL-10 levels in a concentration-independent
manner (p < 0.05). TGF-β levels showed no variation
among all groups (data not shown).
Melittin effects on NO and H2O2
In Figs. 5 and 6, it was demonstrated that melittin did
not alter levels of either NO or H2O2 in uninfected
macrophages. Conversely, infected macrophages treated
with melittin showed reduced NO and H2O2 levels when
compared to untreated macrophages (p < 0.05).
Discussion
Peptides derived from animal toxins represent an
inexhaustible source of candidate compounds for drug
discovery and design, resulting in a reduced probability of
drug resistance through a rapid elimination of microor-
ganisms [7]. Adade et al. [7] evaluated the effect of natural
melittin against epimastigote, trypomastigote and amasti-
gote forms of T. cruzi; the peptide was able to affect the
growth, viability and ultrastructure of amastigotes at
concentrations 15- to 100-fold smaller than the toxic
concentrations. These effects were also observed in
other microorganisms [27]. According to Klocek and
Seelig [28] melittin, at 8 and 14 μg/mL, demonstrated
cytotoxicity to hamster ovary cells (CHO) and also to
glycosaminoglycan-deficient cells (CHO-745), respect-
ively. Similarly, Maher and McClean [29] investigated
the cytotoxicity of melittin against HT29 intestinal
Fig. 2 Determination of IL-12 concentration (pg.mL−1) in the
supernatant of uninfected macrophages (n) and infected macrophages
(i) after melittin treatment (0, 0.7, 1.47 and 2.5 μg.mL−1) at 24, 48 and
72 h. Data are presented as mean of three independent measurements.
*p< 0.05 for infected cells versus non-infected cells (24, 48 and 72 h)
without melittin addition. ● p< 0.05, for 24 h treatment with 2.5 versus
0.7 μg.mL−1 melittin of non-infected cells
Fig. 3 Determination of TNF-α concentration (pg.mL−1) in the
supernatant of uninfected macrophages (n) and infected macrophages
(i) after melittin treatment (0, 0.7, 1.47 and 2.5 μg.mL−1) at 24, 48 and
72 h. Data are presented as mean of three independent measurements.
* p< 0.05 for 72 h infect cells versus 24, 48 and 72 h non-infected cells,
without melittin addition. ● p< 0.05, for 24 h treatment with 0.7 μg.mL−1
melittin versus non-infected cells. Δp< 0.05 for 24, 48 and 72 h treatment
with 2.5 μg.mL−1 melittin versus infected non-treated cells
Table 1 Antileishmanial and mammalian cytotoxicity of whole venom and melittin
IC50 (μg.mL
−1) (95 % CI)
L. (L.) infantum Cytotoxicity (macrophages)
promastigotes amastigotes
Crude venom 87.0 (76.91 to 99.22) n.d. 27.59 (20.63 to 36.90)
Melittin 28.29 (23.97 to 33.39) 1.40 (1.21 to 1.63) 5.73 (5.08 to 6.44)
Miltefosine 6.69 (6.29 to 7.11) 6.87 (4.71 to 10.01) 49.72 (39.85 to 63.98)
IC50: 50 % inhibitory concentration; 95 % CI: 95 % confidence interval; n.d.: not determined
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epithelial cells and Caco-2, with respective IC50 values
of 3.4 μg.mL−1 and 5.2 μg.mL−1. Despite the absence
in the literature of an in vitro toxicity of natural
melittin to macrophages, our results corroborated
previously published studies.
Our data demonstrated that melittin was approxi-
mately 3-fold more effective against Leishmania
infantum promastigotes than the whole venom. Diaz-
Achirica et al. [30] evaluated the activity of melittin
against Leishmania donovani promastigotes and dem-
onstrated an IC50 value of 0.87 μg.mL
−1, causing
damage to the plasma membrane of the parasite. In
our study, Leishmania infantum promastigotes were
about 32-fold more resistant than L. donovani
reported above.
For decades, the effect of animal toxins on the
immune system has been extensively investigated. It
has been known that these toxins have the capacity
to modulate the innate and adaptive immune re-
sponses [31–33]. In addition, the balance between the
host and parasite factors that control the activation/
deactivation of macrophages determines the outcome
of the infected cells. Macrophages are the major
effector cells responsible for elimination of parasites,
which can be activated by distinct signals leading to
their development into functionally distinct subsets
with different disease outcomes. Thus, appropriate
activation of macrophages is crucial for eliminating
the intracellular pathogen [34]. Immune response in
leishmaniasis was clearly described in the murine
model as a Th2 response in active disease and a Th1
response during the elimination of infection and cure.
In humans, the dichotomy is not well established
when compared to the murine model, and disease
progression is determined by the changing cytokine
profile. Our results showed that melittin stimulated
the production of interleukin IL-12 in a time- and
dose-dependent manner. On the other hand, the
infection diminished the levels of this cytokine,
whereas melittin treatment stimulated IL-12 produc-
tion at its 50 % inhibitory concentration. These re-
sults suggest that melittin may eliminate the parasite
via an indirect effect, by modulating pro-inflammatory
interleukin IL-12. Other studies have shown that IL-
12 plays a role in protecting the host during Leish-
mania infection by promoting a Th1 response and
controlling the parasitic replication [35–37]. Our data
Fig. 5 Determination of NO levels in the supernatant of uninfected
macrophages (n) and infected macrophages (i) after melittin
treatment (0, 0.7, 1.47 and 2.5 μg.mL−1) at 24, 48 and 72 h. Data are
presented as mean of three independent measurements.* p < 0.05
for infected cells versus non-infected cells (24, 48 and 72 h) without
melittin addition. All treated infected cells (24, 48 and 72 h; 0,
0.7, 1.47 and 2.5 μg.mL−1) are statistically different (p < 0.05) of
the corresponding non-treated cells
Fig. 4 Determination of IL-10 concentration (pg.mL−1) in the
supernatant of uninfected macrophages (n) and infected macrophages
(i) after melittin treatment (0, 0.7, 1.47 and 2.5 μg.mL−1) at 24, 48 and
72 h. Data are presented as mean of three independent
measurements. ● p < 0.05, for 48 and 72 h treatment with
2.5 μg.mL−1 melittin versus non-infected cells. Δ p < 0.05 for
24 h treatment with 2.5 μg.mL−1 melittin versus non-infected
non-treated cells. All treated infected cells (24, 48 and 72 h; 0,
0.7, 1.47 and 2.5 μg.mL−1) were statistically different (p < 0.05)
of the corresponding non-treated cells
Fig. 6 Determination of H2O2 levels in the supernatant of
uninfected macrophages (n) and infected macrophages (i) after
melittin treatment (0, 0.7, 1.47 and 2.5 μg.mL−1) at 24, 48 and 72 h.
Data is presented as mean of three independent measurements.*p
< 0.05 for infected cells versus non-infected cells (24, 48 and 72 h)
without melittin addition. All treated infected cells (24, 48 and 72
h; 0, 0.7, 1.47 and 2.5 μg.mL−1) were statistically different (p < 0.05)
of the corresponding non-treated cells
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have also shown that melittin eliminated the intracel-
lular amastigotes with an IC50 value about 20-fold
smaller than that needed for the extracellular promas-
tigotes, suggesting the participation of macrophages
in its lethal effect.
TNF-α is a pro-inflammatory cytokine involved in
the activation of macrophages and, together with
IFN-γ, contributes to antiparasitic activity [38]. Al-
though in our study melittin induced a significant
decrease of TNF-α levels in infected macrophages, an
effective antileishmanial activity was observed after
melittin treatment in macrophages. Considering that
an excess of TNF-α in the spleen has been described
to contribute to a progressive cellular damage and
also immunological dysfunction [39, 40], the observed
downregulation of TNF-α induced by melittin could
be a possible advantage to a future experimental
study.
The cytokines IL-10 and TGF-β have been in-
volved in homeostatic mechanisms of leishmaniasis
by limiting the tissue damage caused by excessive
inflammation. However, elevated levels of these cyto-
kines have also been ascribed to the persistence of
the infection [41]. It has also been reported that
patients with active VL present high serum IL-10
levels prior to treatment, indicating their association
with disease persistence [42, 43]. According to our
results, the interaction of melittin with infected
macrophages, decreased the IL-10 production when
compared to untreated cells. Taken together, these
findings suggest that the antiparasitic activity (of
melittin) may also be ascribed to the upregulation of
IL-12 levels and the downregulation of IL-10 levels,
resulting in a reduced in vitro infection. Conversely,
melittin did not exert an effect on TGF-β levels, and
augmented the production of IL-10 in uninfected
macrophages. These results are in agreement with
the observations of Lapara and Kelly [44], who
verified an increase in IL-10 production in macro-
phages infected by Leishmania.
Nitric oxide (NO) and hydrogen peroxide (H2O2)
perform a fundamental role in the defense of macro-
phages [45–47]. In our assays, elevated levels of NO and
H2O2 were found in Leishmania-infected macrophages,
but upon treatment with melittin, a strong inhibition of
these metabolites was observed. These observations
corroborates Kwon et al. [48] and Moon et al. [49], who
demonstrated the capacity of melittin to inhibit NO
production. The elimination of intracellular amastigotes
via an NO-independent pathway has also been described
by Costa-Silva et al. [50]. The authors demonstrated the
antileishmanial activity of a natural phenylpropanoid
dimer on L. donovani macrophage infection, with similar
diminutions in IL-10 levels.
Conclusions
The results showed that melittin exerts in vitro activ-
ity against Leishmania (L.) infantum promastigotes
and intracellular amastigotes and can act indirectly on
intracellular amastigotes through a macrophage im-
munomodulatory effect.
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